HCAL
UTHR icon

HURRICANE CAPITAL ADVISORS LLC’s United Therapeutics UTHR Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-175
Closed -$104K – 947
2026
Q1 		$104K Buy
175
+20
+13% +$10K 0.03% 388
2025
Q4 		$75.5K Sell
155
-31
-17% -$14.4K 0.02% 478
2025
Q3 		$78K Hold
186
– – 0.02% 461
2025
Q2 		$53.4K Buy
+186
New +$55.6K 0.01% 491

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

HURRICANE CAPITAL ADVISORS LLC's UTHR Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 175 shares — an estimated $104K sold.

HURRICANE CAPITAL ADVISORS LLC first reported a position in UTHR in Q2 2025 and held it in 4 quarters. The position peaked at $104K in Q1 2026. 887 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • HURRICANE CAPITAL ADVISORS LLC sold 175 United Therapeutics shares in Q2 2026, an estimated $104K.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in United Therapeutics in Q2 2025 and held it in 4 quarters.
  • HURRICANE CAPITAL ADVISORS LLC's United Therapeutics position peaked at $104K in Q1 2026.
  • 887 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.